Bariatric Surgery and Consequences for Mother and Baby in Pregnancy
BAMBI
The Effect of Gastric Bypass Surgery on Glucose Metabolism, Gestational Weight Gain and Fetal Growth in Subsequent Pregnancy
1 other identifier
interventional
46
1 country
2
Brief Summary
Background Roux-en-Y gastric bypass (RYGB) is a well-established treatment of obesity, most often performed in women during their reproductive years. Adverse events related to RYGB include hypoglycemia. Though usually attenuated in pregnancy, the incretin response is reinforced in subjects with RYGB and the resulting changes in insulin and glucagon responses together with the resultant weight loss are possible underlying mechanisms for hypoglycemia. The majorities of women who have undergone RYGB conceive shortly after RYGB and have an increased risk for inappropriate gestational weight gain (GWG) and thereby fetal growth restriction. However, studies of hypoglycemia and GWG in pregnant women following RYGB are lacking. Objective In women with previous RYGB we aim to investigate a) glucose level and incretin response during a mixed meal test (MMT) in early and late pregnancy, b) trimester specific incidence of postprandial hypoglycemia and c) fetal growth. Methods 20 women with RYGB and 20 age-, BMI- and parity-matched controls will be studied with a) 2nd and 3rd trimester 4-hour liquid MMTs, b) 6-days Continuous Glucose Monitoring (CGM) once every trimester and post partum and c) maternal and fetal anthropometrics including antenatal ultrasound examinations and neonatal DXA-scans. The primary outcomes are nadir plasma glucose levels during the 4-hour liquid MMT, number of hypoglycemic episodes during CGM and birthweight standard deviation scores. Discussion A better understanding of maternal metabolism and fetal growth in women with RYGB will support risk stratification, patient information and management both before and during pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2018
CompletedFirst Posted
Study publicly available on registry
October 19, 2018
CompletedStudy Start
First participant enrolled
April 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 11, 2022
CompletedJuly 18, 2022
July 1, 2022
3.2 years
October 15, 2018
July 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Plasma glucose
Nadir plasma glucose levels during a 4-hour liquid MMT
Changes in plasma glucose during 4 hour test
Plasma glucose
Number of hypoglycemic episodes during CGM
Nuber of episodes during 14 days monitoring
Z-score
Birthweight standard deviation score
Measured immediately after birth
Study Arms (2)
Women with RYGB and fetus/ child
OTHER20 pregnant women with previous gastric bypass surgery. During pregnancy the women will be tested with mixed meal test and continuous glucose monitoring for the diagnosis of hypoglycemia. Ultrasounds of fetal growth will be performed and after birth anthropometrics of the newborn will be meaured including a DXA-scan to estimate bodycomposition.
Matched controls and fetus/ child
OTHER20 pregnant women matched on age, prepregnancy-BMI and parity (n = 20). During pregnancy the women will be tested with mixed meal test and continuous glucose monitoring for the diagnosis of hypoglycemia. Ultrasounds of fetal growth will be performed and after birth anthropometrics of the newborn will be meaured including a DXA-scan to estimate bodycomposition.
Interventions
All women will have mixed meal test, continous glucose monitoring and antenatal ultrasounds performed. The children born of these women will have DXA-scans performed after birth.
Eligibility Criteria
You may qualify if:
- GB group: pregnant women with RYGB (n = 20)
- non-GB group: pregnant women matched on age, prepregnancy-BMI and parity (n = 20)
- neonates: offspring of abovementioned women (n = 40)
You may not qualify if:
- multiple pregnancy
- age below 18 and above 45 years
- ongoing smoking and substance abuse
- severe psychiatric disorder
- severe chronic disease
- diabetes
- women with pre-gestational diabetes (type1 or 2) prior to RYGB
- women with Gestational Diabetes Mellitus (GDM) in a previous pregnancy will not be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- Odense University Hospitalcollaborator
Study Sites (2)
Odense University Hospital
Odense, Fyn, 5000, Denmark
Hospital of South West Jutland
Esbjerg, 6700, Denmark
Related Publications (1)
Stentebjerg LL, Madsen LR, Stoving RK, Hartmann B, Holst JJ, Vinter C, Juhl CB, Hojlund K, Jensen DM. Altered postprandial glucose metabolism and enteropancreatic hormone responses during pregnancy following Roux-en-Y gastric bypass: a prospective cohort study. BMJ Open Diabetes Res Care. 2025 Mar 20;13(2):e004672. doi: 10.1136/bmjdrc-2024-004672.
PMID: 40113260DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louise L Stentebjerg, MD
Clinical Institue, University of Southern Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investiagtor, MD, PhD-student
Study Record Dates
First Submitted
October 15, 2018
First Posted
October 19, 2018
Study Start
April 17, 2019
Primary Completion
July 11, 2022
Study Completion
July 11, 2022
Last Updated
July 18, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share